Terns Pharmaceuticals Financial Overview
Terns Pharmaceuticals's market cap is currently $4.24B. The company's EPS TTM is $-0.27; its P/E ratio is -38.66; Terns Pharmaceuticals is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
